Ostergaard; Soren
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ostergaard; Soren.The latest application filed is for "anti-human interleukin-20 antibodies".
- Ostergaard; Soren - Bronshoj N/A DK
- Ostergaard; Soren - Broenshoej DK
- OSTERGAARD; SOREN - COPENHAGEN O DK
- Ostergaard; Soren - Bagsvaerd DK
- Ostergaard; Soren - Copenhagen DK
- Ostergaard; Soren - DK-2700 Bronshoj DK
- Ostergaard, Soren - Copenhagen N DK
| Patent | Date |
|---|---|
| Conjugated proteins with prolonged in vivo efficacy Grant 8,865,868 - Behrens , et al. October 21, 2 | 2014-10-21 |
| Anti-human Interleukin-20 Antibodies App 20130039923 - Pass; Jesper ; et al. | 2013-02-14 |
| Anti-human interleukin-20 antibodies Grant 8,287,861 - Pass , et al. October 16, 2 | 2012-10-16 |
| Long-Acting Y2 and/or Y4 Receptor Agonists App 20110275559 - Ostergaard; Soren ; et al. | 2011-11-10 |
| Conjugated Proteins With Prolonged In Vivo Efficacy App 20110223151 - Behrens; Carsten ; et al. | 2011-09-15 |
| Insulin and IGF-1 Receptor Agonists and Antagonists App 20110124556 - PILLUTLA; RENUKA ; et al. | 2011-05-26 |
| Anti-Human Interleukin-20 Antibodies App 20110091475 - Pass; Jesper ; et al. | 2011-04-21 |
| Igf-1r Binding Proteins And Antagonists App 20110039779 - Ostergaard; Soren ; et al. | 2011-02-17 |
| Ligands for the HisB10 Zn.sup.2 + sites of the R-state insulin hexamer Grant 7,879,893 - Olsen , et al. February 1, 2 | 2011-02-01 |
| Peptides Derivatized With A-b-c-d- And Their Therapeutical Use App 20100261637 - Spetzler; Jane ; et al. | 2010-10-14 |
| Insulin and IGF-1 Receptor Agonists and Antagonists App 20090192072 - Pillutla; Renuka ; et al. | 2009-07-30 |
| NCAM binding compounds Grant 7,402,560 - Ronn , et al. July 22, 2 | 2008-07-22 |
| Glucose dependent release of insulin from glucose sensing insulin derivatives Grant 7,316,999 - Hoeg-Jensen , et al. January 8, 2 | 2008-01-08 |
| Insulin And Igf-1 Receptor Agonists And Antagonists App 20070265189 - Pillutla; Renuka ; et al. | 2007-11-15 |
| Peptide antagonists of the human urokinase receptor and method for selecting them Grant 7,026,282 - Ploug , et al. April 11, 2 | 2006-04-11 |
| Pharmaceutical preparations comprising acid-stabilised insulin App 20060069013 - Ostergaard; Soren ; et al. | 2006-03-30 |
| Ncam binding compounds App 20050222041 - Biilmann, Lars Christian Ronn ; et al. | 2005-10-06 |
| Therapeutic use of factor XI App 20050181978 - Rojkjaer, Rasmus ; et al. | 2005-08-18 |
| NCAM binding compounds App 20050153888 - Ronn, Lars Christian ; et al. | 2005-07-14 |
| NCAM binding compounds Grant 6,887,844 - Ronn , et al. May 3, 2 | 2005-05-03 |
| Method for preparing a ligand presenting assembly (LPA), an LPA and uses thereof App 20040086949 - Holm, Arne ; et al. | 2004-05-06 |
| Isulin and IGF-1 receptor agonists and antagonists App 20030236190 - Pillutla, Renuka ; et al. | 2003-12-25 |
| Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer App 20030229120 - Olsen, Helle Birk ; et al. | 2003-12-11 |
| Insulin and IGF-1 receptor agonists and antagonists App 20030195147 - Pillutla, Renuka ; et al. | 2003-10-16 |
| Novel Osp-C derived peptide fragments App 20030138866 - Mathiesen, Marianne Jartved ; et al. | 2003-07-24 |
| Glucose dependent release of insulin from glucose sensing insulin derivatives App 20020028767 - Jensen, Thomas Hoeg ; et al. | 2002-03-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 